Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about gene therapy
Recent news which mentions gene therapy
< Previous
1
2
3
Next >
Applied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Months
May 17, 2022
Tickers
AGTC
Tags
Phase 2 Trial
Market News
gene therapy
From
Benzinga
Adverum Bio Posts Additional Efficacy, Safety Data From ADVM-022 Gene Therapy In Wet AMD
May 02, 2022
Tickers
ADVM
Tags
Penny Stocks
General
gene therapy
From
Benzinga
FDA Gives Green Signal To Pfizer's Duchenne Gene Therapy Trial
April 28, 2022
Tickers
PFE
Tags
General
PFE
Large Cap
From
Benzinga
Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
April 25, 2022
Tickers
OCGN
Tags
General
Penny Stocks
Small Cap
From
Benzinga
Creative Biolabs Announces Sponsorship and Exhibition at PEGS Boston 2022
April 21, 2022
Tags
antibody
gene therapy
cell therapy
From
PRUnderground
Amicus Shares Encouraging Long-Term Data Of AT-GAA Study In Pompe Disease
March 16, 2022
Tickers
FOLD
Tags
General
Movers
FOLD
From
Benzinga
FDA Recommends At Least 15 years Of Follow-Up For Genome Editing Product Trials
March 15, 2022
Tickers
BLUE
NTLA
Tags
Small Cap
FDA
gene therapy
From
Benzinga
Why Bluebird Bio Shares Are Tumbling Today
March 07, 2022
Tickers
BLUE
Tags
News
why it's moving
Trading Ideas
From
Benzinga
Gene Therapy Player Amicus Therapeutics Terminates SPAC Merger, Shares Fall
February 24, 2022
Tickers
ARYD
FOLD
Tags
Movers
General
FOLD
From
Benzinga
Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
February 22, 2022
Tickers
TAK
TKPHF
Tags
Market News
gene therapy
Biotech
From
Benzinga
FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
February 18, 2022
Tickers
BMRN
Tags
General
BMRN
News
From
Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
February 09, 2022
Tickers
RGNX
Tags
Phase 1 Trial
RGNX
Small Cap
From
Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
February 09, 2022
Tickers
AVRO
Tags
AVRO
News
Benzinga
From
Benzinga
Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial
February 08, 2022
Tickers
SGMO
Tags
News
Biotech
SGMO
From
Benzinga
Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO Transition
February 01, 2022
Tickers
SIOX
Tags
Management
Penny Stocks
General
From
Benzinga
Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial
January 31, 2022
Tickers
TSHA
Tags
Market News
gene therapy
Health Care
From
Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
January 27, 2022
Tickers
TSHA
Tags
General
Movers
Briefs
From
Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
January 25, 2022
Tickers
FBIO
MBIO
Tags
Benzinga
Biotech
Health Care
From
Benzinga
FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies
January 18, 2022
Tickers
BLUE
Tags
Small Cap
General
BLUE
From
Benzinga
Sarepta Abandons Lysogene-Partnered Pivotal-Stage Gene Therapy Candidate
January 13, 2022
Tickers
SRPT
Tags
Health Care
SRPT
Biotech
From
Benzinga
Bluebird bio Lays Out Planned Updates Ahead Of J.P. Morgan Healthcare Conference
January 11, 2022
Tickers
BLUE
Tags
Market News
gene therapy
Benzinga
From
Benzinga
BioMarin's Hemophilia Gene Therapy Meets Efficacy Endpoints At Two Year Analysis
January 10, 2022
Tickers
BMRN
Tags
General
Hemophilia A
Briefs
From
Benzinga
Pfizer's Duchenne Gene Therapy Trial Put On FDA Hold After Patient Death
December 21, 2021
Tickers
PFE
Tags
General
Movers
PFE
From
Benzinga
Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
December 21, 2021
Tickers
ADVM
Tags
ADVM
Age/Related Macular Degeneration
gene therapy
From
Benzinga
Why Are Bluebird Bio Shares Trading Lower Today?
December 20, 2021
Tickers
BLUE
Tags
Sickle Cell Disease
News
Briefs
From
Benzinga
Bluebird bio's Neurodegenerative Disease Gene Therapy Under Priority FDA Review, Despite Clinical Hold
December 20, 2021
Tickers
BLUE
Tags
Health Care
Benzinga
Briefs
From
Benzinga
UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
December 16, 2021
Tickers
QURE
Tags
Movers
General
Briefs
From
Benzinga
New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
December 13, 2021
Tickers
BLUE
Tags
ASH21
Small Cap
Market News
From
Benzinga
Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
December 13, 2021
Tickers
BLUE
Tags
Health Care
Benzinga
Biotech
From
Benzinga
Selecta's Gene Therapy Trial For Genetic Metabolic Disorder Put On FDA Hold
November 26, 2021
Tickers
SELB
Tags
News
SELB
Trading Ideas
From
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.